Aesthetic surgery journal · 2026
Oncoplastic Breast Reconstruction With J-scar Mammaplasty: Outcomes and Versatility of an Innovative Technique.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bianchi Alessandro, Visconti Giuseppe, Barone Adesi Liliana, Scardina Lorenzo, Sanchez Martin, Di Leone Alba, Franceschini Gianluca, Salgarello Marzia
Аннотация
BACKGROUND: The Oncoplastic Breast Surgery represents a philosophy that prioritizes both oncologic and aesthetic outcomes, introduced to overcome the limitations of conventional breast-conserving surgery. Over the years, it has demonstrated oncological safety along with numerous advantages, particularly related to patients' satisfaction and quality of life, which make acceptable complication rate as high as 16%.
OBJECTIVES: The J-mammaplasty is rarely cited in the oncoplastic approach, while it represents the standard of choice at our Institution. The aim of this study is to report our large experience of J-mammaplasty in level II oncoplastic breast surgery.
METHODS: This study enrolled 157 patients who underwent quadrantectomies and J-scar oncoplasties over a period of 3 years. Patients' demographics and morphological breast features were collected preoperatively using photos, while procedure specific variables were recorded intraoperatively. Complications were identified during follow-up visits. After a minimum of 12 months, surgeon and patients' reported outcomes were recorded.
RESULTS: J-type oncoplastic reduction mammaplasty was optimally applied to a wide range of patients' characteristics, including large breasts and 3rd degree ptosis, as well as different tumour features like location, with lateral quadrants being the most common. The overall complication rate was 7%.
CONCLUSIONS: The J mammoplasty has been applied to oncoplastic breast surgery and refined for the reconstructive purpose for over 20 years at our Institution. It represents a highly versatile, safe technique with high patients' satisfaction.
OBJECTIVES: The J-mammaplasty is rarely cited in the oncoplastic approach, while it represents the standard of choice at our Institution. The aim of this study is to report our large experience of J-mammaplasty in level II oncoplastic breast surgery.
METHODS: This study enrolled 157 patients who underwent quadrantectomies and J-scar oncoplasties over a period of 3 years. Patients' demographics and morphological breast features were collected preoperatively using photos, while procedure specific variables were recorded intraoperatively. Complications were identified during follow-up visits. After a minimum of 12 months, surgeon and patients' reported outcomes were recorded.
RESULTS: J-type oncoplastic reduction mammaplasty was optimally applied to a wide range of patients' characteristics, including large breasts and 3rd degree ptosis, as well as different tumour features like location, with lateral quadrants being the most common. The overall complication rate was 7%.
CONCLUSIONS: The J mammoplasty has been applied to oncoplastic breast surgery and refined for the reconstructive purpose for over 20 years at our Institution. It represents a highly versatile, safe technique with high patients' satisfaction.